Dreep
AI-powered precision supplements - tailored to your body, adapting in real time, effortlessly.
Company Overview
Snapshot
Founded in March 2021 by Avi Ifrah and Yuval Israeli, Dreep operates with 1–10 employees. The company has raised $1.53M across four funding rounds and holds one patent. In March 2025, Dreep secured a grant, signaling continued development in its personalized health system.
Business overview
Dreep is a science-backed health system that provides personalized supplements through an AI-powered application and a smart countertop dispenser. The core technology adapts in real time to individual biology by syncing with wearables, lab data, and lifestyle inputs to deliver precise daily nutrient blends. Serving the digital healthcare and medical devices sectors, Dreep operates within the broader Health Tech & Life Sciences industry, targeting both consumers and healthcare organizations.
Log in to access full profile ›Company Intelligence Q&A
- What is Dreep's primary product offering?
- Dreep offers an AI-powered health system that delivers personalized supplements through a smart countertop dispenser, adapting to individual biological data from wearables, lab results, and lifestyle inputs.
- When was Dreep founded and by whom?
- Dreep was founded in March 2021 by Avi Ifrah and Yuval Israeli.
- What is Dreep's total disclosed funding?
- Dreep has raised a total of $1.53M across four funding rounds. The company's last disclosed funding was $450K in May 2023, which was a SAFE round.
- What is Dreep's current employee count?
- Dreep currently operates with 1–10 employees.
- What is Dreep's business model?
- Dreep operates with both B2B2C and B2C business models, indicating a strategy to reach consumers directly and through other businesses.